Skip to main content

Table 3 Average voluntary acceptance within the 5-min assessment window at each dose assessment

From: Acceptance of oclacitinib maleate (Apoquel®) chewable tablets in client-owned dogs with allergic and atopic dermatitis

Day

AM

PM

Number Consumed

Number of Doses

Voluntary Acceptance Rate (%)

Number Consumed

Number of Dosesa

Voluntary Acceptance Rate (%)

0

111

119a

93.3

110

121

90.9

1

109

120a

90.8

109

120b

90.8

2

111

120b

92.5

112

120b

93.3

3

111

120b

92.5

110

119b

92.4

4

110

119b

92.4

108

119b

90.8

5

107

119b

89.9

107

119b

89.9

6

109

119b

91.6

109

119b

91.6

  1. aData point removed due to Owner mis-dosing (e.g., using pill pocket, not dosing) during the 5-min voluntary acceptance assessment
  2. bDog removed from study due to adverse health event